Form 4 for LDOS Leidos
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-15 · accession 0001628280-22-006392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-16 | 2022-03-15 | LDOS | WILLIAMS NOEL B | Dir | M - OptEx | $31.62 | +10.5K | 17.3K | +156% | +$332.7K |
| D | 2022-03-16 | 2022-03-15 | LDOS | WILLIAMS NOEL B | Dir | M - OptEx | $0.00 | -10.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | M | A | 10,523 | $31.62 | 17,263.84 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-15 | M | D | 10,523 | $0.00 | 0 | D | $31.62 · 2016-06-12 to 2022-06-11 | 10,523 Common Stock | (F1) This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016. |